Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Haas

Showing results (161-170 of 296) with videos related to

Pageof 30
Sort By:
Leukemia Research|May 2, 2015
Change of prognosis of patients with myelodysplastic syndromes during the last 30 yearsJudith Neukirchen, Kathrin Nachtkamp, Jennifer Schemenau, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Biochemistry|March 17, 2004
Structure of Helicobacter pylori catalase, with and without formic acid bound, at 1.6 A resolutionPeter C Loewen, Xavi Carpena, Carme Rovira, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2019
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous LeukemiaThomas Schroeder, Nadija Wegener, Michael Lauseker, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
The Journal of Biological Chemistry|May 21, 2011
BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activityNozomi Ishijima, Masato Suzuki, Hiroshi Ashida, et al.
Leukemia & Lymphoma|June 11, 2011
Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantationRoland Fenk, Vanessa Liese, Florian Neubauer, et al.
Frontiers in Cellular and Infection Microbiology|January 4, 2021
Inhibition of Type IV Secretion Activity and Growth of <i>Helicobacter pylori</i> by Cisplatin and Other Platinum ComplexesClara Lettl, Franziska Schindele, Giambattista Testolin, et al.
Leukemia Research|November 6, 2012
Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blastsAnna Maassen, Corinna Strupp, Aristoteles Giagounidis, et al.
European Journal of Haematology|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDSChristina Rautenberg, Michael Lauseker, Jennifer Kaivers, et al.
Pageof 30

Showing results (161-170 of 296) with videos related to

Sort By:
Pageof 30
Leukemia Research|May 2, 2015
Change of prognosis of patients with myelodysplastic syndromes during the last 30 yearsJudith Neukirchen, Kathrin Nachtkamp, Jennifer Schemenau, et al.
Haematologica|December 6, 2006
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Biochemistry|March 17, 2004
Structure of Helicobacter pylori catalase, with and without formic acid bound, at 1.6 A resolutionPeter C Loewen, Xavi Carpena, Carme Rovira, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2019
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous LeukemiaThomas Schroeder, Nadija Wegener, Michael Lauseker, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
The Journal of Biological Chemistry|May 21, 2011
BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activityNozomi Ishijima, Masato Suzuki, Hiroshi Ashida, et al.
Leukemia & Lymphoma|June 11, 2011
Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantationRoland Fenk, Vanessa Liese, Florian Neubauer, et al.
Frontiers in Cellular and Infection Microbiology|January 4, 2021
Inhibition of Type IV Secretion Activity and Growth of <i>Helicobacter pylori</i> by Cisplatin and Other Platinum ComplexesClara Lettl, Franziska Schindele, Giambattista Testolin, et al.
Leukemia Research|November 6, 2012
Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blastsAnna Maassen, Corinna Strupp, Aristoteles Giagounidis, et al.
European Journal of Haematology|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDSChristina Rautenberg, Michael Lauseker, Jennifer Kaivers, et al.
Pageof 30